Literature DB >> 33004378

Update on breast cancer diagnosis and management: new topics for primary care.

Julie Cox1, Amir Bhatti2, Yitka Graham3, Daniela Lee4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33004378      PMCID： PMC7518917          DOI： 10.3399/bjgp20X712985

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  3 in total

1.  Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

Authors:  Gunter von Minckwitz; Chiun-Sheng Huang; Max S Mano; Sibylle Loibl; Eleftherios P Mamounas; Michael Untch; Norman Wolmark; Priya Rastogi; Andreas Schneeweiss; Andres Redondo; Hans H Fischer; William Jacot; Alison K Conlin; Claudia Arce-Salinas; Irene L Wapnir; Christian Jackisch; Michael P DiGiovanna; Peter A Fasching; John P Crown; Pia Wülfing; Zhimin Shao; Elena Rota Caremoli; Haiyan Wu; Lisa H Lam; David Tesarowski; Melanie Smitt; Hannah Douthwaite; Stina M Singel; Charles E Geyer
Journal:  N Engl J Med       Date:  2018-12-05       Impact factor: 176.079

Review 2.  CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data.

Authors:  Jo Anne Zujewski; Lawrence Rubinstein
Journal:  NPJ Breast Cancer       Date:  2017-07-20

Review 3.  Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials.

Authors: 
Journal:  Lancet Oncol       Date:  2017-12-11       Impact factor: 41.316
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.